These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12172393)

  • 21. The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia.
    Tandirerung FJ
    Curr Cardiol Rep; 2022 Nov; 24(11):1669-1677. PubMed ID: 36083530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patients.
    Versmissen J; Oosterveer DM; Yazdanpanah M; Mulder M; Dehghan A; Defesche JC; Kastelein JJ; Sijbrands EJ
    Eur Heart J; 2011 Feb; 32(4):469-75. PubMed ID: 20595220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia.
    van der Net JB; Versmissen J; Oosterveer DM; Defesche JC; Yazdanpanah M; Aouizerat BE; Steyerberg EW; Malloy MJ; Pullinger CR; Kane JP; Kastelein JJ; Sijbrands EJ
    Atherosclerosis; 2009 Apr; 203(2):472-8. PubMed ID: 18775537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evaluation of cascade testing for familial hypercholesterolemia.
    Morris JK; Wald DS; Wald NJ
    Am J Med Genet A; 2012 Jan; 158A(1):78-84. PubMed ID: 22139944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Need to change the direction of cholesterol-related medication--a problem of great urgency].
    Okuyama H
    Yakugaku Zasshi; 2005 Nov; 125(11):833-52. PubMed ID: 16272805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
    Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
    J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
    Neil HA; Huxley RR; Hawkins MM; Durrington PN; Betteridge DJ; Humphries SE;
    Atherosclerosis; 2003 Sep; 170(1):73-8. PubMed ID: 12957684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of coronary heart disease in familial hypercholesterolemia].
    Miserez AR; Keller U
    Ther Umsch; 1994 Oct; 51(10):671-6. PubMed ID: 7839323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment.
    Hardcastle SJ; Legge E; Laundy CS; Egan SJ; French R; Watts GF; Hagger MS
    Int J Behav Med; 2015 Feb; 22(1):92-100. PubMed ID: 24585182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
    Sinan ÜY; Sansoy V
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between LDL receptor activity and development of coronary heart disease in Japanese cases with heterozygous familial hypercholesterolemia.
    Yamashita S; Kawamoto T; Ueyama Y; Funahashi T; Hara H; Hirobe K; Matsuzawa Y; Yamamoto A; Tarui S
    Artery; 1987; 15(1):24-43. PubMed ID: 3435251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia.
    Cenarro A; Artieda M; Castillo S; Mozas P; Reyes G; Tejedor D; Alonso R; Mata P; Pocoví M; Civeira F;
    J Med Genet; 2003 Mar; 40(3):163-8. PubMed ID: 12624133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive family history for coronary heart disease and 'midband lipoproteins' are potential risk factors of carotid atherosclerosis in familial hypercholesterolemia.
    Taira K; Bujo H; Kobayashi J; Takahashi K; Miyazaki A; Saito Y
    Atherosclerosis; 2002 Feb; 160(2):391-7. PubMed ID: 11849663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Goldberg AC; Hopkins PN; Toth PP; Ballantyne CM; Rader DJ; Robinson JG; Daniels SR; Gidding SS; de Ferranti SD; Ito MK; McGowan MP; Moriarty PM; Cromwell WC; Ross JL; Ziajka PE
    J Clin Lipidol; 2011; 5(3):133-140. PubMed ID: 21600517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incidence of familial defective apolipoprotein B-100 in cases of patients diagnosed with familial hypercholesterolemia].
    Kalina A; Czeizel E; Romics L; Pados G; Reiber I; Dósa A; Hermányi I; Lakatos Z; Tarján J; Kollega-Tarsoly E; Kovács M; Szalai C; Császár A
    Orv Hetil; 1998 Mar; 139(13):755-9. PubMed ID: 9578704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview.
    Hutter CM; Austin MA; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):430-5. PubMed ID: 15321839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.